Track market-moving stories before they get noisy

13.61K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

On October 06, 2026, Corteva Inc CTVA shares rose 12.3% to a current price of $13.91. This move comes amid a 52-week range of $9.08 to $14.44, reflecting a robust price performance over the past year.

GF Value™ verdict: Current price is $13.91, which is 38.5% above the GF Value™ of $10.04, indicating the stock is overvalued. GF Score™: CTVA has a score of 77/100, suggesting it is above average in terms of overall quality. Notable signal: Insiders have sold $0.6 million over the past 12 months without any buying activity.Is CTVA Overvalued or Undervalued?Corteva Inc's current market price of $13.91 is significantly higher than the GF Value™ of $10.04, translating to a 38.5% overvaluation. The GF Value™ is GuruFocus' proprietary estimate of a stock's intrinsic value, which is based on historical trading multiples, past business growth, and future performance estimates. This stark difference suggests that investors may be paying a premium for the stock, which poses a risk if the company's fundamentals do not support such a valuation.

The GF Valuation label classifies CTVA as "Significantly Overvalued," further highlighting the concern surrounding its current price. Investors looking for a margin of safety should be cautious, as overvaluation can lead to potential price corrections in the future.

How Does CTVA's Valuation Compare to Its History?Metric Current Historical P/E (TTM) 9.2x 5.9x (5-Year Median) Forward P/E 3.3x N/ACTVA's current P/E (TTM) of 9.2x is 55% above its 5-year median P/E of 5.9x, suggesting that the stock is trading at a premium compared to its historical valuation metrics. This analysis aligns with the GF Value™ verdict, indicating that CTVA is overvalued based on its historical earnings multiples.

What Does CTVA's GF Score™ Tell Us?The GF Score™ measures a company's overall quality by evaluating several factors, including financial strength, profitability, growth potential, valuation, and momentum. Corteva's GF Score™ of 77/100 indicates above-average quality, with notable strengths in financial stability and profitability.

Metric Rating GF Score™ 77/100 Financial Strength 7/10 Profitability 7/10 Growth 5/10 Valuation 5/10 Momentum 6/10The scores indicate that CTVA has solid financial strength and profitability, ranked at 7/10. However, its growth and valuation ranks of 5/10 suggest that there may be limitations in these areas, aligning with the concerns raised about its overvaluation.

What Are Gurus and Insiders Doing with CTVA?Currently, 11 gurus hold shares of Corteva Inc, with 6 adding to their positions and 6 trimming their stakes in recent quarters. This mixed activity among institutional investors suggests a cautious sentiment surrounding the stock. Additionally, insider activity reveals that insiders have sold $0.6 million worth of shares over the past year without any purchases, which could imply a lack of confidence in the stock's current valuation from those closest to the company.

The balance of guru activity, coupled with insider selling, paints a picture of wariness about the stock's high valuation, further reinforcing the notion that CTVA may be overvalued at its current price.

What This Means for InvestorsIn summary, based on the GF Value™ analysis, Corteva Inc CTVA is deemed overvalued at its current price of $13.91, which is significantly above the estimated fair value of $10.04. While the company shows strengths in financial performance, the high valuation combined with insider selling raises concerns about the sustainability of its current price level. For more detailed information, visit the Corteva Inc (CTVA) stock page and explore further insights on its valuation and performance.

Frequently Asked QuestionsWhat is CTVA's GF Score™?

CTVA has a GF Score™ of 77/100, indicating above-average quality based on various factors such as financial strength and profitability.

Is CTVA overvalued or undervalued?

CTVA is currently overvalued, with a market price of $13.91 that is 38.5% above its GF Value™ of $10.04.

What is CTVA's P/E ratio?

CTVA's P/E (TTM) ratio is 9.2x, which is 55% higher than its 5-year median P/E of 5.9x, indicating that it is trading at a premium compared to its historical valuation.

This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Disclosures I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.

Starting the week on a positive note, Corteva (CTVA +12.91%) stock rose 4% yesterday, outperforming the S&P 500's 0.7% gain. And the market's appetite for agricultural stocks continues today, thanks to an analyst’s bullish outlook on Corteva.

As of 1:40 p.m. ET, Corteva shares are up 12.2%.

One firm believes shares are sitting in the bargain binUpgrading it from neutral to overweight, JPMorgan assigned a $19 price target to Corteva stock today. Based on yesterday's closing price of $12.39, the $19 price target implies 53.3% upside.

Today's Change

(

12.91

%) $

1.60

Current Price

$

13.99

According to Thefly.com, JPMorgan took the bullish stance on Corteva stock, believing that it's now undervalued following the Oct. 1 spinoff of the company's advanced seed and genetics business.

Building on several years of success in its crop protection business, Corteva believes it's well-positioned for future growth, now that it's no longer focused on the advanced seed and genetics business. From 2020 through 2025, for example, Corteva's crop protection business grew sales by over $1 billion while expanding segment-level operating earnings before interest, taxes, depreciation, and amortization (EBITDA) margins by about 250 basis points.

Is now the time to plant Corteva stock in your portfolio?While JPMorgan believes that Corteva stock has ample room to run, prospective investors should take this outlook with a grain of salt, remembering that this is merely one firm's opinion -- not a guarantee that the stock will, in fact, soar. A better course of action at this point is to check in on what the company said in early November, when it reports third-quarter 2026 financial results, to see how things are proceeding following the spinoff of the advanced seed business. In the meantime, there are plenty of other agriculture stocks to consider.

JPMorgan Chase is an advertising partner of Motley Fool Money. Scott Levine has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends JPMorgan Chase. The Motley Fool has a disclosure policy.

Shares of Corteva, Inc. (NYSE: CTVA - Get Free Report) gapped up before the market opened on Tuesday after JPMorgan Chase and Co. upgraded the stock from a neutral rating to an overweight rating. The stock had previously closed at $12.39, but opened at $13.08. JPMorgan Chase and Co. now has a $19.00 price target on

On October 05, 2026, Corteva Inc (CTVA) shares rose 3.9% today, currently trading at $12.39. The stock has experienced a 52-week range between $9.08 and $14.44,

Corteva shareholders woke up to what looked like an 83% crash, but the real story is what they now own across two tickers and a lawsuit that could unwind the entire split.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

On October 1, 2026, anyone who checked Corteva (NYSE:CTVA | CTVA Price Prediction) in a brokerage app saw what looked like a collapse. The stock fell 83.82% in a single session and closed at $12.56, down from a prior close of $77.65.

The value of a Corteva position now sits in two tickers. Corteva finished spinning off its seed business into a separate company, Vylor (NYSE:VYLR), and the drop on the screen simply reflects that business leaving the parent.

Corteva said holders of record on September 24 received one Vylor share for every Corteva share they owned. That leaves holders with two very different companies to evaluate. One of these companies sells seed, and the other sells farm chemicals, and a lawsuit naming both was filed the same day the split closed.

What Happened to Your Account In a spin-off, one company becomes two. Existing holders receive shares of the new company while the parent’s share price falls by the value of the business that left.

Vylor traded at $67.46 on its first day. At that price, one Corteva share plus one Vylor share was worth $80.02, above the $77.65 prior close. Vylor’s first-day close was approximately $68.26.

Vylor said the distribution is tax-free for US holders. Cash paid for fractional shares is taxable.

Two Very Different Businesses Vylor holds the seed and genetics business, including Pioneer and Brevant brands, targeting 2029 net sales of $11.2 billion to $11.9 billion. Seed is an intellectual-property business built on trait licensing and long development cycles.

Corteva kept crop protection: herbicides, insecticides, and fungicides. In the second quarter of 2026, seed sales were $4.532 billion and flat, while crop protection brought in $1.847 billion and fell 4%.

Why Management Split Them A combined company can hide its stronger business inside its weaker one, while a pure seed company will be valued on its own multiple, and a crop-protection company judged on its own results. Luke Kissam, Corteva’s chief executive, said, “This is a new day for Corteva.” The company guided to about $350 million in one-time separation costs.

Fifteen states and Guam sued both companies in Indiana. The suit says the spin-off is a fraudulent transfer designed to keep assets from creditors with PFAS claims. Corteva called the claims speculative and unproven.

The company also said, “Corteva itself never made or sold PFAS products.” If the suit wins, a court could pull the separated company back into the liability, wiping out the clean break both sides are counting on.

What Could Change the Outlook for Corteva and Vylor Vylor likely holds the stronger position. The remaining Corteva is the smaller business, with falling sales and generic competition that seed traits protect it from.

Corteva has also not announced a dividend policy, so any yield you see quoted is based on the old combined company, and Vylor has no trading history yet, so its first-day price is only a starting point for evaluating the company.

If Corteva’s first standalone third-quarter 2026 report shows crop protection sales growing again and comes with a clear dividend, I am wrong about CTVA.

Contact [email protected] for any questions or corrections.

Corteva CTVA shares are undergoing a massive price adjustment on October 1st, plunging rather sharply after the market opened.

While a glance at CTVA stock might look alarming, the crash isn’t because of a sudden operational collapse or unexpected earnings miss.

Instead, it marks the planned execution of a major corporate restructuring.

Corteva officially completed the separation of its massive seed and advanced genetics division into a newly independent, publicly traded enterprise, shedding massive market value to form a standalone agriculture powerhouse.

The main force driving Corteva stock price down today is the official debut of Vylor Inc. (VYLR) on the New York Stock Exchange.

By spinning off its advanced seed and genetics division, Corteva transferred a substantial portion of its total enterprise capitalization into the new entity.

Under the terms of the split, Corteva shareholders of record as of September 24 received pro-rata VYLR common shares while keeping their existing CTVA stakes.

The resulting price drop in Corteva reflects this equity transfer rather than an actual loss of wealth, as investors' combined holdings across CTVA and VYLR preserve their underlying portfolio value.

The transaction almost faced a last-minute disruption after the State of California filed a motion for a temporary restraining order – alleging the spin-off was designed to shield valuable seed assets from historical environmental liabilities related to PFAS chemicals.

However, on September 30, a US District Court denied California’s motion, arguing the state had waited until mere days before closing despite knowing about the plans for nearly a year.

This critical legal clearance removed the final obstacle blocking the corporate separation, allowing Corteva and Vylor Inc. to execute the stock distribution as scheduled on October 1 without lingering regulatory delays.

With the Vylor separation complete, Corteva Inc emerges as a lean, pure-play global leader in crop protection.

For long-term investors, today’s crash offers a fresh baseline valuation to evaluate the streamlined business.

CTVA shares now focus entirely on high-margin crop protection solutions – backed by $11 billion innovation pipeline that has consistently delivered margin expansion.

Meanwhile, risk-tolerant growth investors can look toward Vylor stock for direct exposure to next-generation hybrid technologies and agricultural gene editing.

Rather than signaling fundamental distress, Corteva’s post-spin profile presents a compelling entry point for investors seeking stable, innovation-driven exposure to crop health and agricultural inputs

Note that Wall Street firms also currently have a consensus Overweight rating on CTVA, signaling continued confidence in what the future holds for the agri-science company.

A rather lucrative 5.92% dividend yield tied to the NYSE-listed firm makes it even more attractive as a long-term holding heading into next year (2027).

Company completes spin-off of seed business, well positioned to advance its robust pipeline with 12 new actives, including 5 biologicals, for launch in the next decade

, /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) today announced it has successfully spun off its advanced seed and genetics business and will move forward as a leading, pure-play global crop protection company.

"This is a new day for Corteva, and we couldn't be more excited as we move forward with greater focus, agility and a renewed commitment to innovation and operational excellence," said Corteva CEO Luke Kissam. "As the challenges facing agriculture continue to evolve, we're ready to meet the needs of the future with the industry's best people, portfolio and pipeline—advancing safe, effective and sustainable solutions that deliver for farmers, our channel partners and our shareholders."

Corteva begins this next chapter with strong momentum and a proven record of excellence in execution. Between 2020 and 2025, the crop protection business increased revenue by over $1 billion while expanding operating EBITDA margins by approximately 250 basis points on a segment basis. This progress includes establishment of an industry-leading biologicals and natural products platform, and intentional evolution of the company's product mix toward differentiated technologies—now representing ~65% of sales—to bring new, critically-needed innovations to farmers.

With an $11 billion crop protection pipeline, world-class R&D capabilities, including our microbial discovery, integrated development, and predictive safety platforms, Corteva's future growth will be driven by innovation farmers need most. Today, the company's nearly 9,000 employees serve growers in approximately 110 countries.

About Corteva
Corteva, Inc. (NYSE: CTVA) is a global crop protection company with a leading portfolio of differentiated solutions, including award-winning conventional chemistries and advantaged biologicals, seed-applied technologies and nature-inspired products that help farmers increase yields and protect crops from the stresses of weather, insects, weeds and diseases. Driven by a robust innovation pipeline, deep customer relationships, operational excellence, and disciplined capital allocation, Corteva is focused on creating value for its farmers, channel partners, employees, shareholders, and the communities in which it operates.

Cautionary Statement on Forward-Looking Statements
Cautionary Statement Regarding Forward-Looking Statements This Current Report on Form 8-K, including the information furnished pursuant to Item 8.01 and Item 9.01 hereto, contains certain forward-looking statements. Words such as "believe," "will," "plan," "may," "expect," "see," and variations of such words and similar future or conditional expressions are intended to identify forward-looking statements. Examples of forward-looking statements include, but are not limited to, Corteva's intent to separate and its related expectations for Corteva and Vylor. These forward-looking statements reflect management's current expectations and are not guarantees of future performance and are subject to a number of risks and uncertainties, many of which are difficult to predict and beyond Corteva's and Vylor's control. Important factors that may affect Corteva's or Vylor's respective businesses and operations and that may cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, whether the objectives of the separation will be achieved; the terms, structure, benefits and costs of any action or transaction resulting from the separation; the timing of any such separation or related action and whether any such separation will be consummated at all; the risk that the announcement of the intended separation could have an adverse effect on the ability of Corteva or Vylor to retain and hire key personnel and maintain relationships with customers, suppliers, employees, shareholders and other business relationships and on its operating results and business generally; the risk the separation could divert the attention and time of each company's management; the risk of any unexpected costs or expenses resulting from the separation process or separation itself; and the risk of any litigation relating to the separation, as well as the risks and uncertainties described in Corteva's and Vylor's risk factors, as they may be amended from time to time, set forth in their respective filings with the U.S. Securities and Exchange Commission. Corteva and Vylor disclaim and do not undertake any obligation to update, revise, or withdraw any forward-looking statement in this press release, except as required by applicable law or regulation.

For more information on Corteva's historical segment performance, please see the "Segment Information" footnotes to Corteva's consolidated financial statements in each of its annual reports on SEC Form 10-K.

SOURCE Corteva, Inc.

, /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) announced today that Vylor Inc., a Delaware corporation and its wholly owned subsidiary ("Vylor"), has received the final results of its previously announced (i) private offers to exchange (with respect to each series, an "Exchange Offer" and together, the "Exchange Offers") any and all of the outstanding senior notes of the series listed in the table below issued by EIDP, Inc., a Delaware corporation and a wholly owned subsidiary of Corteva ("EIDP" and such notes, collectively, the "EIDP Notes"), to the extent held by eligible holders, for a corresponding series of notes to be newly issued by Vylor (collectively, the "Vylor Notes") and (ii) related consent solicitations (the "Consent Solicitations") made by Vylor on behalf of EIDP to adopt certain proposed amendments to the indentures governing the EIDP Notes. The Exchange Offers and Consent Solicitations expired at 5:00 p.m., New York City time, on September 30, 2026 (the "Expiration Date").

The table below sets forth, for each series of EIDP Notes, the principal amount validly tendered and not validly withdrawn as of the Expiration Date.

EIDP Notes Validly
Tendered and Not
Validly Withdrawn by the

Expiration Date

Title of
Series of
EIDP
Notes

CUSIP No.
and ISIN of
EIDP Notes

Aggregate
Principal
Amount of
EIDP Notes
Outstanding

Vylor Notes
to be
Issued in
Exchange
for EIDP
Notes

Principal
Amount

Percentage

2.300% Senior
 Notes due 2030

263534CP2

 US263534CP24

$

500,000,000

2.300% Senior Notes
due 2030

$434,841,000

86.97 %

5.125% Senior Notes

 due 2032

263534CS6

 US263534CS62

$

500,000,000

5.125% Senior Notes

 due 2032

$476,214,000

95.24 %

4.800% Senior Notes
due 2033

263534CR8
US263534CR89

$

600,000,000

4.800% Senior Notes

 due 2033

$527,584,000

87.93 %

The Exchange Offers and Consent Solicitations were made upon the terms and conditions set forth in an exchange offer memorandum and consent solicitation statement, dated August 6, 2026 (as amended or supplemented, the "Offering Memorandum"), copies of which were made available to holders of the EIDP Notes eligible to participate in the Exchange Offers and Consent Solicitations. Each Exchange Offer and Consent Solicitation is conditioned upon, among other things, the consummation of Corteva's planned separation into two independent, publicly traded companies, one comprising its current crop protection business and the other comprising its current seed business to be owned and conducted, directly or indirectly, by Vylor (the "Separation"). As of the Expiration Date, other than the consummation of the Separation, all conditions to the Exchange Offers and Consent Solicitations were satisfied. Therefore, settlement of the Exchange Offers and Consent Solicitations is expected to occur substantially simultaneously with the consummation of the Separation, which, as previously announced, is expected to be on or about October 1, 2026 (the "Settlement Date"), subject to satisfaction or waiver of the conditions thereto.

Subject to the terms and conditions set forth in the Offering Memorandum, each eligible holder of EIDP Notes will receive, for each $1,000 principal amount of the applicable series of EIDP Notes validly tendered and not validly withdrawn by 5:00 p.m., New York City time, on August 19, 2026 (the "Early Tender Deadline") and accepted for exchange in the applicable Exchange Offer, (i) an equal principal amount of Vylor Notes of the corresponding series and (ii) a cash payment (with respect to each series, the "Cash Consideration" and, together with such amount of Vylor Notes, the "Total Exchange Consideration"). The Cash Consideration is approximately $2.90 per $1,000 principal amount for the 2.300% Senior Notes due 2030, approximately $2.67 per $1,000 principal amount for the 5.125% Senior Notes due 2032 and approximately $2.86 per $1,000 principal amount for the 4.800% Senior Notes due 2033. The Vylor Notes will have the same interest payment dates, maturity date and interest rate as the EIDP Notes of the corresponding series. Interest on the applicable series of Vylor Notes issued in the related Exchange Offer will accrue from (and including) the date on which such Vylor Notes are issued in exchange for the corresponding series of EIDP Notes.

Eligible holders who validly tendered their EIDP Notes after the Early Tender Deadline but on or prior to the Expiration Date are eligible to receive $970 principal amount of the applicable series of Vylor Notes per $1,000 principal amount of the corresponding series of EIDP Notes validly tendered (the "Exchange Consideration") but no Cash Consideration.

In addition, all eligible holders whose EIDP Notes were validly tendered and accepted for exchange in the Exchange Offers and Consent Solicitations will receive a cash payment equal to the accrued and unpaid interest on their EIDP Notes accepted for exchange from the last interest payment date of the applicable EIDP Notes preceding the Settlement Date up to, but excluding, the Settlement Date.

The Exchange Offers and Consent Solicitations were made only to holders of EIDP Notes who satisfied the eligibility conditions described under "Disclaimer" below.

Disclaimer

This press release is issued pursuant to Rule 135c under the Securities Act of 1933, as amended (the "Securities Act"). This press release is neither an offer to sell nor the solicitation of an offer to buy the Vylor Notes or any other securities and shall not constitute an offer, solicitation or sale in any jurisdiction in which, or to any person to whom, such an offer, solicitation or sale is unlawful. The Exchange Offers and Consent Solicitations have not been and will not be registered under the Securities Act, or the securities laws of any other jurisdiction, and, accordingly, the Vylor Notes will be subject to transfer restrictions unless and until the Vylor Notes are registered or exchanged for registered notes. The Vylor Notes will be issued in reliance upon exemptions from, or in transactions not subject to, registration under the Securities Act. The Exchange Offers and Consent Solicitations were made only to, and the Vylor Notes will be offered for exchange only to, holders of EIDP Notes who are (i) reasonably believed to be "qualified institutional buyers" (as defined in Rule 144A under the Securities Act) in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act, and (ii) outside the United States, persons who are not, and who are not acting for the account or benefit of, "U.S. persons" (as defined in Rule 902 under the Securities Act) in compliance with Regulation S under the Securities Act. The Vylor Notes were not offered or sold in the United States or to U.S. persons (as defined in Rule 902 under the Securities Act) unless the transaction is registered under the Securities Act, an exemption from the registration requirements of the Securities Act is available or the transaction is not subject to registration under the Securities Act.

The Exchange Offers and Consent Solicitations were made only pursuant to the Offering Memorandum. The Offering Memorandum and other documents relating to the Exchange Offers and Consent Solicitations were distributed only to holders of EIDP Notes who confirmed that they are within the categories of eligible participants in the Exchange Offers and Consent Solicitations. None of Vylor, its directors or officers, the dealer managers and solicitation agents, the exchange agent, the information agent, the trustees for the Vylor Notes or the EIDP Notes, their respective affiliates, or any other person is making any recommendation as to whether holders should tender their EIDP Notes in the Exchange Offers or deliver related consents in the Consent Solicitations.

The complete terms and conditions of the Exchange Offers and Consent Solicitations are set forth in the Offering Memorandum. The Exchange Offers and Consent Solicitations were made pursuant to the Offering Memorandum. The Exchange Offers and Consent Solicitations were not made to holders of EIDP Notes in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction. NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY OTHER REGULATORY BODY HAS REGISTERED, RECOMMENDED OR APPROVED OF THE VYLOR NOTES OR PASSED UPON THE ACCURACY OR ADEQUACY OF THE OFFERING MEMORANDUM. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

About Corteva

Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.

Cautionary Statement on Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the U.S. federal securities laws about Corteva, Vylor, EIDP, the Exchange Offers and Consent Solicitations and the Separation, including but not limited to all statements about the timing and consummation of the Exchange Offers and Consent Solicitations and the Separation, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current assumptions regarding future business and financial performance and, by their nature, address matters that are uncertain to different degrees. You can identify forward-looking statements by the use of words such as "plans," "expects," "will," "anticipates," "believes," "intends," "projects," "estimates," "outlook" or other words of similar meaning. These forward-looking statements are subject to risks and uncertainties that could cause actual results to be materially different from those set forth in such forward-looking statements, including but not limited to, the risk: (i) that general economic and capital markets conditions may adversely affect the Exchange Offers and Consent Solicitations or the Separation; (ii) that the conditions to the Exchange Offers and Consent Solicitations or the Separation may not be satisfied or waived; (iii) that any event, change or other circumstance could give rise to the termination of the Exchange Offers and Consent Solicitations and/or the Separation; (iv) of the effects that any termination of the Separation may have on Corteva or its subsidiaries; (v) that legal proceedings may be instituted related to the Separation or otherwise; (vi) of unexpected costs, charges or expenses; and (vii) of other risks and uncertainties described in Corteva's and EIDP's filings with the U.S. Securities and Exchange Commission (the "SEC"), including under the heading "Risk Factors" (Item 1A) in Corteva's most recently filed Annual Report on Form 10-K and in Corteva's subsequent Quarterly Reports on Form 10-Q, and in other documents that Corteva or EIDP files or furnishes with the SEC. Neither Corteva nor EIDP undertakes any obligation to update or revise any forward-looking statement, except as required by applicable law.

SOURCE Corteva, Inc.

, /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) and Inari, the SEEDesign™ company, announced they have reached a confidential settlement agreement to resolve the lawsuit filed by Corteva in September 2023 that was pending in the United States District Court for the District of Delaware.  As part of the settlement, Inari has agreed to destroy Corteva material it accessed from seed depositories and material developed from the deposits and assign to Corteva the intellectual property related to its edited versions of Corteva events. In addition, Corteva and Inari have agreed to negotiate certain licensing arrangements. Other terms of the settlement are confidential.

Global patent and plant variety protection systems that protect agricultural innovation help promote continued investment, competition and collaboration in the development of improved seed products that benefit farmers. Patent depositories and their procedures on access to biological material serve an important function as part of these systems.

The rulings in this case reinforce applicable rights with respect to seed deposits. Corteva and Inari agree that it is important to abide by applicable patent and other laws and contracts relating to deposited materials. 

The case is Corteva Agriscience LLC, Pioneer Hi-Bred International, Inc., and Agrigenetics, Inc. v. Inari Agriculture, Inc. and Inari Agriculture NV, C.A. No. 23-1059 (JFM).

About Corteva

Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.

About Inari

Inari is the SEEDesign™ company, revolutionizing plant performance with high-impact, high-value solutions for broadacre crops. At its core is the AI-enabled SEEDesign™ Platform, the industry's most sophisticated performance accelerator integrating breakthroughs in genomics, machine learning and gene editing technology to deliver ROI from the lab to the field. Founded by Flagship Pioneering in 2016, Inari is based in Cambridge, Mass., with additional sites in West Lafayette, Ind., and Ghent, Belgium. Inari brings together a global team of more than 200 employees dedicated to solving the critical issues of food security and sustainability. To learn more, visit Inari.com.

SOURCE Corteva Agriscience

Key Takeaways ADM combines global processing scale with growth in nutrition, natural colors and precision fermentation.CTVA gains from Enlist adoption, branded corn leadership in Brazil and differentiated crop protection.ADM's 9.7% three-month return and 15.18X forward P/E compare with CTVA's 0.3% rise and 20.41X. Archer-Daniels-Midland Company (ADM - Free Report) and Corteva, Inc. (CTVA - Free Report) sit at different but strategically important points of the global agricultural value chain. ADM derives its strength from an expansive origination, transportation, processing and ingredients network spanning oilseeds, grains, biofuels and nutrition, giving it scale and flexibility when trade flows shift.

Corteva, by contrast, competes through intellectual property, seed genetics and differentiated crop-protection technologies sold directly into the farm economy. Its Enlist platform is expected to cover about 65% of U.S. soybean acres in 2026, while Corteva's branded corn business holds the No. 1 position in Brazil. Thus, the face-off is less about two identical competitors and more about ADM's infrastructure-led scale versus Corteva's technology-led market share and pricing power.

The Investment Case for ADMArcher-Daniels-Midland commands a strong position across the global agricultural value chain, supported by its extensive origination, processing, transportation and distribution network. The company’s broad asset footprint gives it flexibility to respond to shifts in commodity flows, trade patterns and regional demand. Recent performance in Ag Services and Oilseeds reflected effective commercial execution and higher utilization across processing assets. ADM’s competitive standing is therefore anchored less in consumer-facing market share and more in its scale across agricultural processing, biofuels, food ingredients and nutrition.

ADM is also reshaping its portfolio toward differentiated, higher-value businesses that can improve the quality of earnings over time. Natural colors have emerged as an important growth avenue as food and beverage manufacturers increasingly move toward cleaner-label formulations. The company is leveraging its established expertise in colors, flavors and formulation capabilities to support customers through this transition. Flavors are also gaining traction across international markets, while improving Specialty Ingredients performance is strengthening the broader Human Nutrition platform.

Innovation remains an important pillar of ADM’s long-term strategy. The company is expanding precision-fermentation capabilities to develop applications across human nutrition, pet food and natural ingredients, while also pursuing opportunities in plant proteins, postbiotics and fiber. These initiatives broaden ADM’s exposure to changing consumer preferences around health, wellness and ingredient transparency. At the same time, investments in automation, digitization and cybersecurity are intended to improve operating efficiency and strengthen the company’s technological foundation across its global operations.

From a financial standpoint, ADM is benefiting from stronger operating performance across its major businesses, with Ag Services and Oilseeds, Carbohydrate Solutions and Nutrition all contributing to improved profitability. Nutrition has shown particularly encouraging margin progress despite softer revenues, supported by Flavors growth and portfolio actions. Healthy cash generation and a manageable leverage position provide ADM with flexibility to fund organic expansion while maintaining capital discipline. The company is prioritizing lower-cost brownfield capacity additions, particularly in crushing and ethanol, which could enhance returns while supporting future growth.

The Investment Case for CTVACorteva holds a strong competitive position across seeds and crop protection, supported by proprietary technology, established brands and growing farmer adoption. Its Enlist platform has become a leading soybean technology in the United States, while the company also maintains a prominent position in branded corn in Brazil. Corteva is looking to deepen its presence in Brazil’s soybean market as well. Its licensing model is broadening the reach of key technologies through independent seed companies, strengthening Corteva’s farm-gate presence beyond its directly marketed brands.

The portfolio is anchored by established seed brands such as Pioneer and Brevant, supported by proprietary germplasm and an expanding trait-licensing business. On the Crop Protection side, Corteva is emphasizing differentiated chemistry, biologicals and newer technologies rather than relying heavily on commoditized products. Its development pipeline includes new active ingredients, biological solutions, hybrid wheat and next-generation traits. This breadth gives Corteva exposure to multiple areas of farmer spending while helping the company position its offerings around yield improvement, crop protection and input efficiency.

Innovation is central to Corteva’s strategy, with gene editing, biotechnology and advanced genetics shaping the next phase of portfolio development. Management is also expanding opportunities beyond traditional corn and soybean markets through hybrid wheat and biofuel-oriented crop systems. Biological products are gaining importance, particularly in Latin America, where farmers are seeking solutions that can support productivity amid elevated fertilizer costs. Corteva’s target customer remains the value-conscious grower willing to adopt premium technologies when they can improve yields, protect crops or enhance farm economics.

Financial performance reflects the benefits of this technology-led positioning. Organic growth has been supported by gains across both Seed and Crop Protection, while favorable price and mix in Seed and rising volumes in newer Crop Protection products have strengthened operating performance. Productivity initiatives, lower input costs and reduced royalty expenses are also supporting margin expansion. Corteva expects its Seed business to move toward a more favorable royalty position, which could further improve earnings quality. The broader investment case rests on converting proprietary innovation, licensing expansion and differentiated products into sustained market penetration and stronger profitability.

How Do Estimates Compare for ADM & CTVA?The Zacks Consensus Estimate for Archer-Daniels-Midland’s fiscal 2026 EPS suggests year-over-year growth of 52.2%, while the estimate for fiscal 2027 indicates an increase of 3.5%. ADM’s EPS estimates have been stable in the past 30 days.

ADM’s Estimate Revision Trend
Image Source: Zacks Investment Research

The Zacks Consensus Estimate for Corteva’s 2026 sales and EPS suggests year-over-year growth of 4.1% and 11.4%, respectively. The EPS estimate has been stable in the past 30 days.

CTVA’s Estimate Revision Trend
Image Source: Zacks Investment Research

Price Performance & Valuation of ADM & CTVAIn the past three months, ADM stock has had the edge in terms of performance, having recorded a total return of 9.7%. This has noticeably outpaced CTVA's 0.3% rise.

ADM vs. CTVA: 3-Month Price Performance
Image Source: Zacks Investment Research

From a valuation perspective, ADM trades at a forward price-to-earnings (P/E) multiple of 15.18X. Moreover, CTVA stock trades above Archer-Daniels-Midland’s forward 12-month P/E multiple of 20.41X.

Image Source: Zacks Investment Research

The valuation gap suggests that investors are currently assigning a richer premium to CTVA, potentially reflecting expectations for stronger growth from its differentiated seed and crop-protection portfolio. In contrast, ADM combines stronger recent share-price performance with a lower earnings multiple, making the valuation comparison particularly noteworthy.

ADM vs. CTVA: Which Is the Better Bet Now?In comparing the two, both companies offer distinct investment narratives, but with different risk-reward profiles. Archer-Daniels-Midland stands out for its diversified agricultural platform, improving operating performance, stronger recent price momentum and relatively attractive valuation. Corteva, on the other hand, offers a technology-driven growth story supported by leadership in seeds, crop protection and biologicals, but its richer valuation makes the near-term setup comparatively less compelling. ADM’s combination of earnings growth prospects, valuation support and stronger market performance gives it an edge at this stage, making it the relatively better bet for investors.

ADM currently sports a Zacks Rank #1 (Strong Buy), while CTVA has a Zacks Rank #3 (Hold).

You can see the complete list of today’s Zacks #1 Rank stocks here.

Investors interested in Agriculture - Operations stocks are likely familiar with Dole (DOLE - Free Report) and Corteva, Inc. (CTVA - Free Report) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.

The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The Zacks Rank is a proven strategy that targets companies with positive earnings estimate revision trends, while our Style Scores work to grade companies based on specific traits.

Dole has a Zacks Rank of #2 (Buy), while Corteva, Inc. has a Zacks Rank of #3 (Hold) right now. This means that DOLE's earnings estimate revision activity has been more impressive, so investors should feel comfortable with its improving analyst outlook. But this is just one factor that value investors are interested in.

Value investors also tend to look at a number of traditional, tried-and-true figures to help them find stocks that they believe are undervalued at their current share price levels.

Our Value category highlights undervalued companies by looking at a variety of key metrics, including the popular P/E ratio, as well as the P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that have been used by value investors for years.

DOLE currently has a forward P/E ratio of 9.90, while CTVA has a forward P/E of 22.40. We also note that DOLE has a PEG ratio of 1.46. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. CTVA currently has a PEG ratio of 2.56.

Another notable valuation metric for DOLE is its P/B ratio of 0.87. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. For comparison, CTVA has a P/B of 2.19.

These are just a few of the metrics contributing to DOLE's Value grade of A and CTVA's Value grade of D.

DOLE sticks out from CTVA in both our Zacks Rank and Style Scores models, so value investors will likely feel that DOLE is the better option right now.

Company forecasts $500 million in NA wheat revenue by 2035, $1 billion by 2040

, /PRNewswire/ -- Ahead of its planned separation on October 1, 2026, Corteva, Inc. (NYSE: CTVA) today confirmed progress of the hybrid wheat technology platform of Vylor, its advanced seed and genetics spin-off, with the announcement of Xpedite™, the system used to create its proprietary hybrid wheat, which will launch in late 2027. Multi-year research trials demonstrate and confirm the hybrid wheat's consistently strong yields as well as its yield stability, or resilience against a variety of adverse conditions including disease and drought.

The company anticipates that hybrid wheat will accelerate the growth of its North America wheat portfolio, resulting in $500 million in revenue by 2035 and $1 billion by 2040, which includes licensing revenue, making wheat the third pillar of Vylor's business, alongside corn and soybeans.

"Wheat is grown on nearly 550 million acres globally and on more than 60 million acres in North America, making it the region's third largest row crop.  It is also, importantly, a critical source of food for hundreds of millions of people, accounting for 20% of calories consumed worldwide. These numbers give a sense of the scale of the impact our technology can have," said future Vylor Chief Commercial and Operations Officer Judd O'Connor. "We're excited to start working with farmers to help them grow more of this critical crop and help meet the needs of a growing global population."

Hybrid seeds are created by crossing two genetically different parents to ultimately produce more resilient, higher yielding plants for farmers. Vylor's hybrid wheat is built on a first-of-its kind system, proprietary and non-GMO; it increases yield potential by 10%1 while using the same amount of land and resources, is more resistant to drought – hybrid wheat created using Xpedite can yield up to 20%2 higher than elite varieties in water-stressed environments – and accelerates the speed to market of new elite germplasm by increasing the scale of parent seed production. As a product of conventional breeding, the hybrid wheat Vylor will launch in North America does not require regulatory approval. 

1

Internal yield testing on launch hybrids: three years (2024, 2025, 2026) of testing with 41 locations in Kansas, Nebraska, Colorado and Oklahoma; and pipeline hybrids: one year (2026) of testing at 18 locations in Kansas, Nebraska, Colorado and Oklahoma.

2

Internal yield testing on launch hybrids: three years (2024, 2025, 2026) of testing with 20 locations in Kansas, Colorado, Nebraska and Oklahoma; and pipeline hybrids: one year (2026) of testing at 10 locations in Kansas, Colorado, Nebraska and Oklahoma

Unlike other wheat hybridization systems that have been known  for decades, Vylor's proprietary technology has been shown in trials to work in 100% of wheat germplasm tested – enabling more rapid genetic gains and delivery of seed at a commercial scale.  The company expects its hybrid wheat technology will, when compared to conventional wheat, double the rate of annual genetic gain by 2040.

Vylor's hybrid wheat delivers grain meeting the same quality standards as varietal wheat and requires no special equipment or management, allowing farmers to maintain their current farming practices. The company will launch Hard Red Winter wheat in 2027 in North America, and expect to add Soft Red Winter in 2029 and Hard Red Spring in 2030 while also expanding to other regions around the world via the company's branded business as well as through licensing and other partnerships, including acquisitions.

Click here to watch the Vylor video about the science of hybrid wheat.

Cautionary and Forward-Looking Statements
Statement under the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995:  Corteva and its respective representatives may from time to time make written or oral statements that are "forward-looking" and provide other than historical information, including statements contained in this press release, in the company's other filings with the Securities and Exchange Commission ("SEC"), and in presentations, reports or letters to its stockholders.

In some cases, the company identified these forward-looking statements by such words or phrases as "plans," "outlook," "will," "is designed to," "is confident that," "expect," "expects," "should," "could," "may," "will continue to," "believe," "believes," "anticipates," "predicts," "forecasts," "estimates," "projects," "potential," "intends," or similar expressions identifying "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on the company's current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. The forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. These statements are qualified by reference to the risk factors included in Part I, Item 1A of Corteva's Annual Report on Form 10-K for the year ended December 31, 2025 (the "2025 Form 10-K"), the section captioned "Forward-Looking Information" in Part II of the 2025 Form 10-K, the "Risk Factors" and "Cautionary Statement Concerning Forward-Looking Statements" sections of the preliminary information statement filed as Exhibit 99.1 to Vylor Inc.'s ("Vylor") Registration Statement on Form 10, as amended, and to similar risk factors and cautionary statements in all other reports and forms filed with the SEC.

We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.  Forward-looking statements are qualified in their entirety by the above cautionary statement. We specifically decline to undertake any obligation, and specifically disclaim any duty, to publicly update or revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events, except as may be required by law.

Examples of forward-looking statements include, but are not limited to, Corteva's intent to separate and its related expectations for Corteva and Vylor, including the anticipated timing, attributes, performance and financial, competitive and other benefits of these and any other products in Vylor's pipeline. These forward-looking statements reflect management's current expectations and are not guarantees of future performance and are subject to a number of risks and uncertainties, many of which are difficult to predict and beyond Corteva's control.

About Vylor
Vylor is an advanced seed and genetics company that has, for more than a century, been focused on delivering groundbreaking innovation to farmers. Anchored in the agriculture industry's most elite germplasm and transformative biotech, Vylor leverages its scientific expertise to deliver next generation technology to help farmers around the world boost yields. With its expertise in advanced science, leading routes-to-market and an expanding licensing business, Vylor drives value and delivers growth for farmers, customers and shareholders – and in doing so, helps feed, fuel and clothe the world.  More information at vylor.com.

SOURCE Corteva Agriscience

Corteva (NYSE:CTVA – Get Free Report) and Kronos Worldwide (NYSE:KRO – Get Free Report) are both materials companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, valuation and institutional ownership.

Dividends Corteva pays an annual dividend of $0.72 per share and has a dividend yield of 0.9%. Kronos Worldwide pays an annual dividend of $0.20 per share and has a dividend yield of 2.5%. Corteva pays out 47.7% of its earnings in the form of a dividend. Kronos Worldwide pays out -21.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Corteva has raised its dividend for 5 consecutive years. Kronos Worldwide is clearly the better dividend stock, given its higher yield and lower payout ratio.

Profitability This table compares Corteva and Kronos Worldwide’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets Corteva 5.66% 10.18% 6.00% Kronos Worldwide -5.63% -12.28% -5.16% Institutional & Insider Ownership 81.5% of Corteva shares are held by institutional investors. Comparatively, 15.1% of Kronos Worldwide shares are held by institutional investors. 0.2% of Corteva shares are held by company insiders. Comparatively, 0.2% of Kronos Worldwide shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Analyst Recommendations This is a breakdown of recent ratings and price targets for Corteva and Kronos Worldwide, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Corteva 0 9 14 0 2.61 Kronos Worldwide 2 1 1 0 1.75 Corteva presently has a consensus target price of $91.50, suggesting a potential upside of 10.76%. Kronos Worldwide has a consensus target price of $8.50, suggesting a potential upside of 5.49%. Given Corteva’s stronger consensus rating and higher probable upside, equities analysts plainly believe Corteva is more favorable than Kronos Worldwide.

Risk and Volatility Corteva has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500. Comparatively, Kronos Worldwide has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500.

Valuation & Earnings This table compares Corteva and Kronos Worldwide”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Corteva $17.40 billion 3.17 $1.09 billion $1.51 54.71 Kronos Worldwide $1.94 billion 0.48 -$110.90 million ($0.95) -8.48 Corteva has higher revenue and earnings than Kronos Worldwide. Kronos Worldwide is trading at a lower price-to-earnings ratio than Corteva, indicating that it is currently the more affordable of the two stocks.

Summary Corteva beats Kronos Worldwide on 13 of the 17 factors compared between the two stocks.

About Corteva (Get Free Report)

Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.

(Get Free Report)

Kronos Worldwide, Inc. produces and markets titanium dioxide pigments (TiO2) in Europe, North America, the Asia Pacific, and internationally. The company produces TiO2 in two crystalline forms, rutile and anatase to impart whiteness, brightness, opacity, and durability for various products, including paints, coatings, plastics, paper, fibers, and ceramics, as well as for various specialty products, such as inks, foods, and cosmetics. It also produces ilmenite, a raw material used directly as a feedstock by sulfate-process TiO2 plants; iron-based chemicals, which are used as treatment and conditioning agents for industrial effluents and municipal wastewater, as well as in the manufacture of iron pigments, cement, and agricultural products; specialty chemicals for use in the formulation of pearlescent pigments, and production of electroceramic capacitors for cell phones and other electronic devices, as well as for use in natural gas pipe, and other specialty applications. In addition, the company provides technical services for its products. It sells its products under the KRONOS brand through agents and distributors to paint, plastics, decorative laminate, and paper manufacturers. The company was founded in 1916 and is headquartered in Dallas, Texas. Kronos Worldwide, Inc. is a subsidiary of Valhi, Inc.

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.

Future crop protection company will be a strongly capitalized market leader with compelling value proposition for farmers, shareholders

, /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) categorically rejects the attempt by a number of State Attorneys General to prevent Corteva's planned separation.  The planned separation of the company will result in the creation of two companies built to lead their respective industries. The crop protection company, which will retain the Corteva brand, will be an innovation-driven market leader at a time when innovative, safe, effective crop protection has never been more needed by farmers fighting intensifying pest, disease and weed pressures that rob yield and threaten food security.

Corteva will vigorously defend its planned separation against the attempt by the State Attorneys General to stop it on the basis of alleged PFAS liabilities. The underlying claims on which this extraordinary relief is sought are speculative and unproven, relying on novel legal theories and groundless assumptions. California and the other States petitioning for this relief do not have judgments against Corteva. They do not even have trials scheduled against Corteva related to PFAS liability.

Moreover, in its seven-year history, Corteva has never made, sold or traded PFOA or PFOS products. Corteva's balance sheet will be well-equipped to cover any liability it might face.

"As we've stated from the beginning, our planned separation is an acknowledgement that our two businesses have different business models and will better deliver for farmers separately than they do together – meaning that the separation should result in stronger companies built for growth," said Corteva Chief Legal Officer Jennifer Johnson. "Corteva neither has nor has demonstrated any intent to hinder, delay, or defraud our creditors."

"Companies need flexibility to engage in transactions like this to continue to innovate and generate value for their customers and shareholders," said Johnson. "States are seeking extraordinary and, we believe, unprecedented relief, and in doing so, they are asking the court to supplant the judgment of our Board of Directors as well as our senior management team. We firmly believe the separation is in the best interest of our stakeholders and empowers each company to pursue its ideal strategy to enhance shareholder value.  We will vigorously defend our ability to make decisions about our own company, including its separation, in every way possible."

About Corteva
Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed and crop protection products. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the Company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.

Cautionary Statement Regarding Forward-Looking Statements
This press release contains certain forward-looking statements. Words such as "believe," "will," "plan," "may," "expect," "see," and variations of such words and similar future or conditional expressions are intended to identify forward-looking statements. Examples of forward-looking statements include, but are not limited to, Corteva's intent to separate and its related expectations for Corteva and Vylor. These forward-looking statements reflect management's current expectations and are not guarantees of future performance and are subject to a number of risks and uncertainties, many of which are difficult to predict and beyond Corteva's and Vylor's control.

Important factors that may affect Corteva's or Vylor's respective businesses and operations and that may cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, whether the objectives of the separation will be achieved; the terms, structure, benefits and costs of any action or transaction resulting from the separation; the timing of any such separation or related action and whether any such separation will be consummated at all; the risk that the announcement of the intended separation could have an adverse effect on the ability of Corteva or Vylor to retain and hire key personnel and maintain relationships with customers, suppliers, employees, shareholders and other business relationships and on its operating results and business generally; the risk the separation could divert the attention and time of each company's management; the risk of any unexpected costs or expenses resulting from the separation process or separation itself; and the risk of any litigation relating to the separation, as well as the risks and uncertainties described in Corteva's and Vylor's risk factors, as they may be amended from time to time, set forth in their respective filings with the U.S. Securities and Exchange Commission. Corteva and Vylor disclaim and do not undertake any obligation to update, revise, or withdraw any forward-looking statement in this press release, except as required by applicable law or regulation.

SOURCE Corteva Agriscience

Chemours (CC.N), DuPont (DD.N) and Corteva (CTVA.N) on Thursday reached a $455 million settlement with North Carolina and 11 ​local entities over PFAS contamination claims tied ‌to Chemours' Fayetteville Works plant and other historical discharges.

Lawsuits accusing major chemical companies of polluting U.S. drinking water ​with toxic PFAS chemicals — a group of ​pollutants referred to as "forever chemicals" — have led ⁠to settlements worth billions of dollars, including one struck by ​the three companies in New Jersey last year.

Payments ​will be made over 15 years, beginning within 30 days of the agreement's execution, and Chemours expects to pay ​about $50 million over the next 12 months, Chemours ​said on Thursday.

In line with a 2021 agreement among the ‌companies, ⁠Chemours will bear 50% of the settlement cost, while DuPont and Corteva will split the remainder.

The North Carolina agreement resolves lawsuits brought by the state ​and local ​governments excluded ⁠from the U.S. public water system class settlement approved in 2024.

It also covers ​North Carolina's claims over PFAS contamination ​unrelated ⁠to Fayetteville Works, including pollution linked to aqueous film-forming foam.

Chemours said the settlement recognizes progress under its ⁠2019 ​consent order with North Carolina, ​including investments to cut PFAS emissions and address off-site impacts.

Platform to accelerate investment in next generation ag-tech innovation

, /PRNewswire/ -- Vylor, the advanced seed and genetics company that will spin-off from Corteva on October 1, 2026, today announced the launch of Vylor Edge, a new investment platform dedicated to accelerating the development of advanced technologies in global agriculture. Vylor Edge will collaborate with start-ups, entrepreneurs, universities and the wider innovation ecosystem through equity investments and strategic partnerships. 

"Vylor Edge will partner with the global scientific community to deliver breakthrough innovations that advance global agriculture and mitigate key production challenges," said Sam Eathington, chief technology officer of the future Vylor. "Pairing Vylor's world class expertise with other technology leaders from around the world will help drive innovation and equip farmers with the tools they need to be successful."

Vylor Edge will initially focus on identifying opportunities across strategic verticals aligned with Vylor's priorities, including gene editing and advanced breeding; protein engineering; as well as artificial intelligence and digital technology platforms. It will also explore opportunities in other areas and sectors to harness technologies applicable to Vylor's business and mission to help farmers feed and fuel the world.

"We are excited to collaborate with entrepreneurs who can benefit from the deep expertise of our dedicated team, as well as Vylor's leading R&D capabilities, global footprint, and go-to-market infrastructure," said Mat Muller,  head of Vylor Edge. "We look forward to supporting the development and commercialization of promising technologies and delivering new innovations to growers."

The Vylor Edge portfolio will be launched with a strong foundation of investments and collaborations that were previously part of Corteva Catalyst™ and are now transitioning to Vylor as part of the company's spin-off from Corteva. Through Vylor Edge, Vylor will continue to support and expand these partnerships while identifying new opportunities to accelerate innovation across global agriculture.

About Corteva

Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed and crop protection products. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.

Cautionary statement

This release contains certain estimates and forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, which are intended to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and may be identified by their use of words like "may," "expects," "will," "aims," "believes," "intends," or other words of similar meaning. All statements that address expectations or projections about the future, including statements about the parties' expectations related to regulatory matters, product development and commercialization, product offerings and product, financial or sustainability performance are forward-looking statements. No obligation to update or revise any forward-looking statement, except as required by applicable law, is hereby undertaken and any such obligation is specifically disclaimed. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements or other estimates is included in the "Risk Factors" section of Corteva's Annual Report on Form 10-K, and as modified by subsequent reports on Form 10-Q and Current Reports on Form 8-K and Vylor's Registration Statement on Form 10.

SOURCE Corteva Agriscience

Investors interested in Agriculture - Operations stocks are likely familiar with Dole (DOLE) and Corteva, Inc. (CTVA). But which of these two stocks offers value investors a better bang for their buck right now?

Bank of New York Mellon Corp bought a new position in Corteva, Inc. (NYSE:CTVA – Free Report) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 4,633,924 shares of the company’s stock, valued at approximately $392,447,000. Bank of New York Mellon Corp owned 0.69% of Corteva at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CTVA. JPL Wealth Management LLC bought a new stake in shares of Corteva in the 3rd quarter worth $25,000. Garton & Associates Financial Advisors LLC bought a new position in Corteva during the fourth quarter valued at about $27,000. Bank of Jackson Hole Trust bought a new position in Corteva during the fourth quarter valued at about $28,000. Cornerstone Financial Management LLC acquired a new position in Corteva during the fourth quarter worth about $29,000. Finally, Elevation Wealth Partners LLC grew its holdings in Corteva by 334.6% during the second quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock worth $29,000 after acquiring an additional 261 shares during the period. 81.54% of the stock is owned by institutional investors.

Corteva Stock Performance Shares of NYSE CTVA opened at $81.84 on Friday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. Corteva, Inc. has a one year low of $60.53 and a one year high of $90.97. The business’s 50-day moving average price is $82.13 and its two-hundred day moving average price is $80.21. The company has a market capitalization of $54.60 billion, a P/E ratio of 54.20, a price-to-earnings-growth ratio of 2.44 and a beta of 0.57.

Corteva (NYSE:CTVA – Get Free Report) last posted its earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping the consensus estimate of $2.24 by $0.06. The company had revenue of $6.38 billion during the quarter, compared to the consensus estimate of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The company’s revenue for the quarter was down 1.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year. Corteva Dividend Announcement The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be paid a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s dividend payout ratio is presently 47.68%.

Analysts Set New Price Targets A number of equities research analysts have weighed in on the stock. Weiss Ratings downgraded shares of Corteva from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, August 3rd. CICC Research lifted their price objective on shares of Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 13th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $101.00 target price on shares of Corteva in a report on Monday, August 3rd. JPMorgan Chase & Co. increased their target price on shares of Corteva from $77.00 to $83.00 and gave the company a “neutral” rating in a research note on Monday, August 3rd. Finally, Mizuho raised their target price on shares of Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a report on Tuesday, July 14th. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $91.50.

Get Our Latest Report on Corteva

Corteva Company Profile (Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Featured Articles Five stocks we like better than Corteva Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.

Advisors Capital Management LLC bought a new position in shares of Corteva, Inc. (NYSE:CTVA – Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund bought 9,002 shares of the company’s stock, valued at approximately $762,000.

Other hedge funds have also modified their holdings of the company. Arbejdsmarkedets Tillaegspension purchased a new position in Corteva during the fourth quarter worth about $23,679,000. Leonteq Securities AG acquired a new position in shares of Corteva in the fourth quarter worth $2,350,000. Brandes Investment Partners LP increased its position in shares of Corteva by 1.1% during the fourth quarter. Brandes Investment Partners LP now owns 2,312,515 shares of the company’s stock worth $155,009,000 after acquiring an additional 24,985 shares during the period. Twin Capital Management Inc. raised its stake in shares of Corteva by 178.9% in the fourth quarter. Twin Capital Management Inc. now owns 25,394 shares of the company’s stock valued at $1,702,000 after acquiring an additional 16,288 shares in the last quarter. Finally, Renaissance Technologies LLC purchased a new position in Corteva in the first quarter valued at $1,222,000. 81.54% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes A number of brokerages have commented on CTVA. Citigroup increased their price objective on shares of Corteva from $85.00 to $86.00 and gave the company a “neutral” rating in a research report on Monday, August 3rd. Weiss Ratings lowered Corteva from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, August 3rd. Barclays lifted their price objective on Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a report on Thursday, June 11th. BNP Paribas Exane raised their price objective on Corteva from $74.00 to $77.00 in a research note on Wednesday, May 6th. Finally, Oppenheimer increased their price objective on Corteva from $89.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, July 23rd. Fourteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat.com, Corteva presently has an average rating of “Moderate Buy” and an average target price of $91.50.

Get Our Latest Stock Report on CTVA Corteva Price Performance NYSE CTVA opened at $81.84 on Friday. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $90.97. The stock has a market capitalization of $54.60 billion, a P/E ratio of 54.20, a P/E/G ratio of 2.44 and a beta of 0.57. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. The business’s fifty day moving average is $82.13 and its two-hundred day moving average is $80.21.

Corteva (NYSE:CTVA – Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The firm had revenue of $6.38 billion for the quarter, compared to the consensus estimate of $6.60 billion. During the same quarter in the previous year, the company earned $2.20 EPS. The business’s revenue for the quarter was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, research analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be given a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio (DPR) is presently 47.68%.

Corteva Company Profile (Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Further Reading Five stocks we like better than Corteva Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.

Bell & Brown Wealth Advisors LLC bought a new position in Corteva, Inc. (NYSE:CTVA – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 14,533 shares of the company’s stock, valued at approximately $1,231,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. BlackRock Inc. purchased a new stake in shares of Corteva during the 2nd quarter valued at about $4,560,180,000. Harris Associates L P lifted its holdings in Corteva by 168.1% in the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock valued at $1,141,268,000 after acquiring an additional 10,675,052 shares during the period. Norges Bank bought a new position in shares of Corteva in the 4th quarter worth approximately $504,001,000. Royal Bank of Canada grew its position in Corteva by 202.1% during the first quarter. Royal Bank of Canada now owns 7,458,624 shares of the company’s stock valued at $624,362,000 after buying an additional 4,989,371 shares during the period. Finally, Bank of New York Mellon Corp purchased a new stake in Corteva during the second quarter valued at approximately $392,447,000. 81.54% of the stock is currently owned by institutional investors.

Corteva Price Performance NYSE CTVA opened at $78.51 on Thursday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $90.97. The company has a market cap of $52.38 billion, a price-to-earnings ratio of 51.99, a PEG ratio of 2.39 and a beta of 0.57. The stock’s fifty day moving average price is $81.92 and its 200 day moving average price is $80.15.

Corteva (NYSE:CTVA – Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, topping the consensus estimate of $2.24 by $0.06. The company had revenue of $6.38 billion for the quarter, compared to the consensus estimate of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. Corteva’s quarterly revenue was down 1.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, equities research analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current year. Corteva Announces Dividend The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be given a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date is Tuesday, September 1st. Corteva’s dividend payout ratio is currently 47.68%.

Wall Street Analysts Forecast Growth A number of brokerages have commented on CTVA. UBS Group reduced their price target on Corteva from $89.00 to $85.00 and set a “neutral” rating for the company in a research report on Tuesday. Morgan Stanley upped their price objective on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a research report on Thursday, May 28th. Oppenheimer increased their target price on shares of Corteva from $89.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, July 23rd. JPMorgan Chase & Co. upped their price target on shares of Corteva from $77.00 to $83.00 and gave the stock a “neutral” rating in a report on Monday, August 3rd. Finally, Weiss Ratings lowered Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, August 3rd. Fourteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, Corteva currently has an average rating of “Moderate Buy” and an average price target of $91.50.

Check Out Our Latest Stock Analysis on CTVA

Corteva Company Profile (Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

See Also Five stocks we like better than Corteva Bloom Energy’s AI Surge Meets a Valuation Reality Check Target Is Winning Shoppers Back—Can the Rally Reach $180? IonQ’s Space Contract Points to a New Frontier for Quantum Investors Is Apple’s AI Strategy Smarter Than Skeptics Think? Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.

Key Takeaways Corteva's Seed sales rose 4%, supported by technology demand, pricing and improved royalty economics.Corteva raised 2026 EBITDA guidance to $4.1-$4.3 billion as productivity actions boost earnings.Corteva faces Crop Protection pricing pressure and execution risks ahead of its planned Oct. 1 separation. Corteva, Inc. (CTVA - Free Report) is showing improving earnings momentum as technology adoption, productivity actions and a stronger Seed business support growth. However, the stock’s valuation and ongoing Crop Protection pricing pressures keep the risk-reward balance more measured. The stock currently carries a Zacks Rank #3 (Hold), with a price target of $81.00 versus a share price of $76.22 as of Aug. 11, 2026.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Corteva delivered a solid first half of 2026, with net sales increasing 4% year over year to $11.28 billion and operating EBITDA rising 10% to $3.70 billion. Operating EPS increased 14% to $3.80. Management raised its full-year outlook and now expects operating EBITDA of $4.1-$4.3 billion and operating EPS of $3.60-$3.80 per share.

Growth Drivers Remain in PlaceThe Seed segment continues to be the primary growth contributor. First-half Seed net sales increased 4% to $7.56 billion, helped by higher price/mix, demand for differentiated germplasm and trait technologies and improved royalty economics. Segment operating EBITDA increased 11% to $3 billion, supported by pricing actions and lower royalty expense.

Corteva’s Crop Protection business is also benefiting from new product adoption. In the first half of 2026, Crop Protection sales increased 3%, with volume growth from new products helping offset a 3% pricing decline caused by competitive conditions, particularly in Latin America.

Productivity initiatives remain another earnings driver. Management cited more than $160 million in cost improvements from lower input costs, manufacturing efficiencies and productivity programs during the first half of 2026.

Separation Adds a Near-Term Execution RiskCorteva is preparing to separate its businesses into two standalone public companies, targeting completion on Oct. 1, 2026. Management has reported that run-rate dis-synergies are largely offset, but remaining steps include final capital structures, Form 10 effectiveness and IT separation activities.

The transition could require additional management focus as Corteva prepares both businesses to operate independently. The company included a $25 million headwind in 2026 guidance related to separation timing.

Valuation Leaves Less Room for ErrorCorteva’s valuation reflects some of the expected earnings improvement. The stock trades at 19.6X forward 12-month earnings, with a PEG ratio of 2.2X. Its Zacks Style Scores include a Value Score of D, Growth Score of F, Momentum Score of C and VGM Score of F.

Image Source: Zacks Investment Research

While earnings growth expectations have improved, valuation remains a concern if Crop Protection pricing pressure persists or separation-related costs weigh on results.

Corteva competes within the broader agricultural sector alongside companies such as Archer Daniels Midland Company (ADM - Free Report) and Adecoagro S.A. (AGRO - Free Report) . Corteva focuses primarily on agricultural technology solutions, including seeds and crop protection products, while ADM operates a large-scale agricultural processing and commodities platform and AGRO has exposure to farming, sugar, ethanol and agricultural production assets.

Bottom LineCorteva’s improving fundamentals are supported by Seed technology demand, new Crop Protection products and cost discipline. The company has raised its 2026 outlook and continues to execute on its separation plan. However, elevated valuation, competitive pricing pressure and execution risks around the separation limit near-term upside potential.

Given the balance between improving earnings trends and valuation concerns, CTVA appears more suitable for investors seeking exposure to agricultural technology growth but willing to accept moderate near-term upside potential.

, /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) announced today that Vylor Inc., a Delaware corporation and its wholly owned subsidiary ("Vylor"), has commenced private offers to exchange (with respect to each series, an "Exchange Offer" and together, the "Exchange Offers") any and all of the outstanding senior notes of the series listed in the table below issued by EIDP, Inc., a Delaware corporation and a wholly owned subsidiary of Corteva ("EIDP" and such notes, collectively, the "EIDP Notes"), to the extent held by eligible holders, for a corresponding series of notes to be newly issued by Vylor (collectively, the "Vylor Notes"). As previously disclosed, Corteva's Board of Directors is pursuing a plan to separate Corteva into two independent, publicly traded companies, one comprising its current crop protection business and the other comprising its current seed business to be owned and conducted, directly or indirectly, by Vylor (the "Separation"). The Exchange Offers and Consent Solicitations (as defined below) are being made in connection with the planned Separation. Each Exchange Offer and Consent Solicitation is conditioned upon, among other things, consummation of the Separation and the receipt, by the applicable Early Tender Deadline (as defined below), of the Requisite Consents (as defined below) to the Proposed EIDP Base Indenture Amendments (as defined below). The Separation is subject to the satisfaction or waiver of certain customary conditions, and Corteva's Board of Directors has the discretion to abandon or to alter the terms of the planned Separation. As publicly announced by Corteva on July 30, 2026, the Separation is currently expected to be consummated on or about October 1, 2026, subject to satisfaction or waiver of the conditions thereto.

The Exchange Offers and Consent Solicitations are being made upon the terms and conditions set forth in an exchange offer memorandum and consent solicitation statement, dated August 6, 2026 (the "Offering Memorandum"), copies of which will be made available to holders of the EIDP Notes eligible to participate in the Exchange Offers and Consent Solicitations.

The Vylor Notes will have the same interest payment dates, maturity date and interest rate as the EIDP Notes of the corresponding series. In addition to the Vylor Notes, eligible holders of EIDP Notes tendered by the applicable Early Tender Deadline and not validly withdrawn before the applicable Withdrawal Deadline (as defined below) will also receive the applicable Cash Consideration (as defined below). The following table sets forth the applicable Total Exchange Consideration (as defined below), which includes the Cash Consideration, and the applicable Exchange Consideration (as defined below) being offered for a series of EIDP Notes:

Total Exchange
Consideration for
EIDP Notes Validly
Tendered by the
Early Tender
Deadline and Not
Validly Withdrawn by
the Withdrawal
Deadline

Exchange
Consideration
for EIDP Notes
Validly
Tendered After
the Early
Tender
Deadline

Title of
Series of
EIDP
Notes

CUSIP No.
and ISIN of
EIDP Notes

Aggregate
Principal
Amount of
EIDP Notes
Outstanding

Vylor Notes
to be
Issued in
Exchange
for EIDP
Notes

Principal
Amount
of Vylor
Notes (1)

Cash
Consideration
(2)

Principal
Amount of
Vylor Notes
(3)

2.300% Senior Notes due 2030

263534CP2 US263534CP24

$

500,000,000

2.300% Senior Notes due 2030

$1,000

$2.50 to $5.00

$970

5.125% Senior Notes due 2032

263534CS6 US263534CS62

$

500,000,000

5.125% Senior Notes due 2032

$1,000

$2.50 to $5.00

$970

4.800% Senior Notes due 2033

263534CR8 US263534CR89

$

600,000,000

4.800% Senior Notes due 2033

$1,000

$2.50 to $5.00

$970

Principal amount of the applicable series of Vylor Notes issued in exchange for each $1,000 principal amount of EIDP Notes of the corresponding series validly tendered by the applicable Early Tender Deadline and not validly withdrawn by the applicable Withdrawal Deadline and accepted for exchange. Per $1,000 principal amount of the applicable series of EIDP Notes validly tendered by the applicable Early Tender Deadline and not validly withdrawn by the applicable Withdrawal Deadline and accepted for exchange, the applicable Cash Consideration will be an amount equal to the product of $2.50 multiplied by a fraction, the numerator of which is the aggregate principal amount of such series of EIDP Notes outstanding as of such Early Tender Deadline and the denominator of which is the aggregate principal amount of such series of EIDP Notes validly tendered by such Early Tender Deadline and not validly withdrawn by the applicable Withdrawal Deadline. As a result, the applicable Cash Consideration for a series of EIDP Notes will range from $2.50 per $1,000 principal amount (if all eligible holders of such series of EIDP Notes tender) to approximately $5.00 per $1,000 principal amount (if eligible holders of a simple majority of the aggregate principal amount of such series of EIDP Notes tender). The applicable Exchange Consideration does not include, and eligible holders tendering after the applicable Early Tender Deadline will not be eligible to receive, any Cash Consideration. The applicable Exchange Consideration involves the issuance of $970 principal amount of the applicable series of Vylor Notes, as opposed to $1,000 principal amount of such Vylor Notes, for each $1,000 principal amount of EIDP Notes of the corresponding series validly tendered after the applicable Early Tender Deadline and accepted for exchange. Concurrently with the Exchange Offers, Vylor is soliciting consents (with respect to the EIDP Base Indenture (as defined below) and the applicable EIDP Supplemental Indenture (as defined below) governing a series of EIDP Notes, a "Consent Solicitation" and together, the "Consent Solicitations") from eligible holders of EIDP Notes, on behalf of EIDP, to adopt certain proposed amendments to the base indenture (the "EIDP Base Indenture") and the supplemental indentures thereto (each, an "EIDP Supplemental Indenture") governing the EIDP Notes. The proposed amendments to the EIDP Base Indenture (the "Proposed EIDP Base Indenture Amendments") would eliminate substantially all of the restrictive covenants and events of default (other than payment-related and bankruptcy-related events of default) from the EIDP Base Indenture. Approval of the Proposed EIDP Base Indenture Amendments requires consents from the holders of at least a majority of the aggregate principal amount of all the EIDP Notes, voting as a single class (the "Requisite Consents"). The Exchange Offers are conditioned upon, among other things, receipt, by the applicable Early Tender Deadline, of the Requisite Consents to the Proposed EIDP Base Indenture Amendments. The proposed amendments with respect to each EIDP Supplemental Indenture (the "Proposed EIDP Supplemental Indenture Amendments" and, together with the Proposed EIDP Base Amendments, the "Proposed Amendments") would eliminate the offer to repurchase upon change of control provisions from the applicable EIDP Supplemental Indenture. Approval of the Proposed EIDP Supplemental Indenture Amendments requires consents from the holders of at least a majority of the aggregate principal amount of the applicable series of EIDP Notes (the "Majority Consents"). The Exchange Offers are not conditioned upon the receipt of the Majority Consents with respect to any EIDP Supplemental Indenture. When an eligible holder validly tenders their EIDP Notes in the applicable Exchange Offer, they are automatically treated as having validly delivered the related consents to the Proposed Amendments with respect to such EIDP Notes. Eligible holders will not be permitted to tender their EIDP Notes without delivering related consents or to deliver related consents without tendering their EIDP Notes.

Each Exchange Offer and Consent Solicitation will expire at 5:00 p.m., New York City time, on September 3, 2026, unless extended or earlier terminated (such date and time, as they may be extended, the "Expiration Date"). Tenders of a series of EIDP Notes may be validly withdrawn at or prior to 5:00 p.m., New York City time, on August 19, 2026, unless extended or earlier terminated with respect to the applicable Exchange Offer (such date and time, as they may be extended, the "Withdrawal Deadline"), but tenders of such EIDP Notes not so validly withdrawn will thereafter be irrevocable, except in certain limited circumstances where additional withdrawal rights are required by law. A valid withdrawal of the applicable series of EIDP Notes at or prior to 5:00 p.m., New York City time, on August 19, 2026 (such date and time, as they may be extended to any date and time that is no later than the Withdrawal Deadline, the "Consent Revocation Deadline") will also constitute the revocation of the related consents. With respect to a series of EIDP Notes, consents may not be revoked after the applicable Consent Revocation Deadline. Vylor reserves the right to terminate, withdraw, amend or extend an Exchange Offer and Consent Solicitation in its sole discretion, subject to the terms and conditions set forth in the Offering Memorandum.

Subject to the terms and conditions set forth in the Offering Memorandum, for each $1,000 principal amount of the applicable series of EIDP Notes validly tendered in the applicable Exchange Offer by 5:00 p.m., New York City time, on August 19, 2026, unless extended or earlier terminated with respect to the applicable Exchange Offer and Consent Solicitation (such date and time, as they may be extended, the "Early Tender Deadline"), and not validly withdrawn by the applicable Withdrawal Deadline, each eligible holder of EIDP Notes will be eligible to receive (i) Vylor Notes of the corresponding series in an equal principal amount as such series of EIDP Notes tendered and accepted for exchange and (ii) a cash payment of an amount equal to the product of $2.50 multiplied by a fraction, the numerator of which is the aggregate principal amount of such series of EIDP Notes outstanding as of the applicable Early Tender Deadline and the denominator of which is the aggregate principal amount of such series of EIDP Notes validly tendered by such Early Tender Deadline and not validly withdrawn by the applicable Withdrawal Deadline (the "Cash Consideration" and, together with such amount of Vylor Notes, the "Total Exchange Consideration"). As a result, the applicable Cash Consideration for a series of EIDP Notes will range from $2.50 per $1,000 principal amount (if all eligible holders of such series of EIDP Notes tender) to approximately $5.00 per $1,000 principal amount (if eligible holders of a simple majority of the aggregate principal amount of such series of EIDP Notes tender).

Eligible holders who validly tender their EIDP Notes after the applicable Early Tender Deadline but on or prior to the Expiration Date will be eligible to receive $970 principal amount of the applicable series of Vylor Notes per $1,000 principal amount of the corresponding series of EIDP Notes validly tendered (the "Exchange Consideration") but no Cash Consideration.

In addition, all eligible holders whose EIDP Notes are validly tendered and accepted for exchange in the Exchange Offers and Consent Solicitations will receive a cash payment equal to the accrued and unpaid interest on their EIDP Notes accepted for exchange from the last interest payment date of the applicable EIDP Notes preceding the Settlement Date up to, but excluding, the Settlement Date.

Assuming the conditions to the Exchange Offers and Consent Solicitations are satisfied or (to the extent permitted) waived, settlement of the Exchange Offers is expected to occur on or about the second business day following the Expiration Date and substantially simultaneously with the consummation of the Separation, unless Vylor extends or terminates the Exchange Offers (such date and time, as the same may be extended, the "Settlement Date"). Accordingly, Vylor may, in its discretion, extend each of the Expiration Date and the Settlement Date as necessary to maintain such sequencing. Interest on the applicable series of Vylor Notes issued in the related Exchange Offer will accrue from (and including) the Issue Date (the date on which such Vylor Notes are issued in exchange for the corresponding series of EIDP Notes).

The Vylor Notes to be issued in the Exchange Offers will be issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. No tender of EIDP Notes of any series will be accepted if it would result in the issuance of less than $2,000 principal amount of the corresponding series of Vylor Notes. If the principal amount of the applicable series of Vylor Notes that would otherwise be required to be delivered in exchange for a tender of the corresponding series of EIDP Notes would not equal $2,000 or an integral multiple of $1,000 in excess thereof, then the principal amount of such Vylor Notes will be rounded down to $2,000 or the nearest integral multiple of $1,000 in excess thereof, and Vylor will pay cash (in lieu of such Vylor Notes not delivered) equal to the remaining portion of the applicable Exchange Consideration for such corresponding series of EIDP Notes plus accrued and unpaid interest with respect to that portion to, but not including, the Settlement Date.

Vylor's obligation to accept and exchange any EIDP Notes validly tendered pursuant to the applicable Exchange Offer is subject to, and conditioned upon, the satisfaction or (to the extent permitted) waiver of certain conditions as set forth in the Offering Memorandum. Each Exchange Offer and Consent Solicitation is conditioned upon, among other things, (i) the consummation of the Separation and (ii) the receipt, by the applicable Early Tender Deadline, of the Requisite Consents to adopt the Proposed EIDP Base Indenture Amendments. Receipt of the Majority Consents to adopt the Proposed EIDP Supplemental Indenture Amendments is not a condition to the consummation of any of the Exchange Offers and Consent Solicitations. Other than the Separation (without the consummation of which the Exchange Offers and Consent Solicitations will not be consummated, neither the applicable Exchange Consideration nor the applicable Total Exchange Consideration will be delivered, and the Proposed Amendments contemplated by the Consent Solicitations will not become effective), Vylor may generally waive any condition with respect to the Exchange Offers and Consent Solicitations, in its sole discretion, at any time prior to the Expiration Date.

The Exchange Offers and Consent Solicitations are being made only to holders of EIDP Notes who satisfy the eligibility conditions described under "Disclaimer" below. Holders of EIDP Notes who desire a copy of the eligibility letter should contact D.F. King & Co., Inc., the information agent and exchange agent for the Exchange Offers and Consent Solicitations, by phone at (800) 283-9185 or by email at [email protected]. Banks and brokers should call (646) 461-2610. The eligibility letter may also be found here: www.dfking.com/vylor. D.F. King & Co., Inc. will also provide copies of the Offering Memorandum to eligible holders of EIDP Notes.

Holders of EIDP Notes are advised to check with any bank, securities broker or other intermediary through which they hold EIDP Notes as to when such intermediary needs to receive instructions from a holder in order for that holder to be able to participate in, or (in the circumstances in which revocation is permitted) revoke their instruction to participate in, the Exchange Offers and Consent Solicitations before the deadlines specified herein and in the Offering Memorandum. The deadlines set by each clearing system for the submission and withdrawal of exchange instructions will also be earlier than the relevant deadlines specified herein and in the Offering Memorandum.

Disclaimer

This press release is issued pursuant to Rule 135c under the Securities Act of 1933, as amended (the "Securities Act"). This press release is neither an offer to sell nor the solicitation of an offer to buy the Vylor Notes or any other securities and shall not constitute an offer, solicitation or sale in any jurisdiction in which, or to any person to whom, such an offer, solicitation or sale is unlawful. The Exchange Offers and Consent Solicitations have not been and will not be registered under the Securities Act, or the securities laws of any other jurisdiction, and, accordingly, the Vylor Notes will be subject to transfer restrictions unless and until the Vylor Notes are registered or exchanged for registered notes. The Vylor Notes will be issued in reliance upon exemptions from, or in transactions not subject to, registration under the Securities Act. The Exchange Offers and Consent Solicitations are being made only to, and the Vylor Notes will be offered for exchange only to, holders of EIDP Notes who are (i) reasonably believed to be "qualified institutional buyers" (as defined in Rule 144A under the Securities Act) in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act, and (ii) outside the United States, persons who are not, and who are not acting for the account or benefit of, "U.S. persons" (as defined in Rule 902 under the Securities Act) in compliance with Regulation S under the Securities Act. The Vylor Notes will not be offered or sold in the United States or to U.S. persons (as defined in Rule 902 under the Securities Act) unless the transaction is registered under the Securities Act, an exemption from the registration requirements of the Securities Act is available or the transaction is not subject to registration under the Securities Act.

The Exchange Offers and Consent Solicitations are being made only pursuant to the Offering Memorandum. The Offering Memorandum and other documents relating to the Exchange Offers and Consent Solicitations will be distributed only to holders of EIDP Notes who confirm that they are within the categories of eligible participants in the Exchange Offers and Consent Solicitations. None of Vylor, its directors or officers, the dealer managers and solicitation agents, the exchange agent, the information agent, the trustees for the Vylor Notes or the EIDP Notes, their respective affiliates, or any other person is making any recommendation as to whether holders should tender their EIDP Notes in the Exchange Offers or deliver related consents to the Proposed Amendments in the Consent Solicitations.

The complete terms and conditions of the Exchange Offers and Consent Solicitations are set forth in the Offering Memorandum. The Exchange Offers and Consent Solicitations are only being made pursuant to the Offering Memorandum. The Exchange Offers and Consent Solicitations are not being made to holders of EIDP Notes in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction. NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY OTHER REGULATORY BODY HAS REGISTERED, RECOMMENDED OR APPROVED OF THE VYLOR NOTES OR PASSED UPON THE ACCURACY OR ADEQUACY OF THE OFFERING MEMORANDUM. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

About Corteva

Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.

Cautionary Statement on Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the U.S. federal securities laws about the Company, Vylor, EIDP, the Exchange Offers and Consent Solicitations and the Separation, including but not limited to all statements about the timing and consummation of the Exchange Offers and Consent Solicitations and the Separation, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current assumptions regarding future business and financial performance and, by their nature, address matters that are uncertain to different degrees. You can identify forward-looking statements by the use of words such as "plans," "expects," "will," "anticipates," "believes," "intends," "projects," "estimates," "outlook" or other words of similar meaning. These forward-looking statements are subject to risks and uncertainties that could cause actual results to be materially different from those set forth in such forward-looking statements, including but not limited to, the risk: (i) that general economic and capital markets conditions may adversely affect the Exchange Offers and Consent Solicitations or the Separation; (ii) that the conditions to the Exchange Offers and Consent Solicitations or the Separation, including the receipt of the Requisite Consents, may not be satisfied or waived; (iii) that any event, change or other circumstance could give rise to the termination of the Exchange Offers and Consent Solicitations and/or the Separation; (iv) of the effects that any termination of the Separation may have on the Company or its subsidiaries; (v) that legal proceedings may be instituted related to the Separation or otherwise; (vi) of unexpected costs, charges or expenses; and (vii) of other risks and uncertainties described in the Company's and EIDP's filings with the U.S. Securities and Exchange Commission (the "SEC"), including under the heading "Risk Factors" (Item 1A) in the Company's most recently filed Annual Report on Form 10-K and in the Company's subsequent Quarterly Reports on Form 10-Q, and in other documents that the Company or EIDP files or furnishes with the SEC. Neither the Company nor EIDP undertakes any obligation to update or revise any forward-looking statement, except as required by applicable law.

SOURCE Corteva Agriscience

Release Date: July 31, 2026For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Strong first-hal

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.

While many investors like to look for momentum in stocks, this can be very tough to define. There is a lot of debate surrounding which metrics are the best to focus on and which are poor quality indicators of future performance. The Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us.

Below, we take a look at Corteva, Inc. (CTVA - Free Report) , a company that currently holds a Momentum Style Score of A. We also talk about price change and earnings estimate revisions, two of the main aspects of the Momentum Style Score.

It's also important to note that Style Scores work as a complement to the Zacks Rank, our stock rating system that has an impressive track record of outperformance. Corteva, Inc. currently has a Zacks Rank of #2 (Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of "A or B" outperform the market over the following one-month period.

You can see the current list of Zacks #1 Rank Stocks here >>>

Set to Beat the Market?Let's discuss some of the components of the Momentum Style Score for CTVA that show why this agriculture shows promise as a solid momentum pick.

Looking at a stock's short-term price activity is a great way to gauge if it has momentum, since this can reflect both the current interest in a stock and if buyers or sellers have the upper hand at the moment. It is also useful to compare a security to its industry, as this can help investors pinpoint the top companies in a particular area.

For CTVA, shares are up 2.23% over the past week while the Zacks Agriculture - Operations industry is down 0.7% over the same time period. Shares are looking quite well from a longer time frame too, as the monthly price change of 4.13% compares favorably with the industry's 0.19% performance as well.

While any stock can see its price increase, it takes a real winner to consistently beat the market. That is why looking at longer term price metrics -- such as performance over the past three months or year -- can be useful as well. Shares of Corteva, Inc. have increased 12.99% over the past quarter, and have gained 23.86% in the last year. In comparison, the S&P 500 has only moved 3.48% and 18.18%, respectively.

Investors should also pay attention to CTVA's average 20-day trading volume. Volume is a useful item in many ways, and the 20-day average establishes a good price-to-volume baseline; a rising stock with above average volume is generally a bullish sign, whereas a declining stock on above average volume is typically bearish. CTVA is currently averaging 3,285,966 shares for the last 20 days.

Earnings OutlookThe Zacks Momentum Style Score encompasses many things, including estimate revisions and a stock's price movement. Investors should note that earnings estimates are also significant to the Zacks Rank, and a nice path here can be promising. We have recently been noticing this with CTVA.

Over the past two months, 3 earnings estimates moved higher compared to none lower for the full year. These revisions helped boost CTVA's consensus estimate, increasing from $3.72 to $3.76 in the past 60 days. Looking at the next fiscal year, 2 estimates have moved upwards while there have been no downward revisions in the same time period.

Bottom LineTaking into account all of these elements, it should come as no surprise that CTVA is a #2 (Buy) stock with a Momentum Score of A. If you've been searching for a fresh pick that's set to rise in the near-term, make sure to keep Corteva, Inc. on your short list.